Covid-19 vaccines: ethical, legal and practical considerations

Amendment No. 4 | Doc. 15212 | 25 January 2021

Signatories:

Mr Aleksandr BASHKIN, Russian Federation, NR ; Ms Vera GANZIA, Russian Federation, UEL ; Mr Leonid KALASHNIKOV, Russian Federation, UEL ; Mr Sergey KISLYAK, Russian Federation, NR ; Mr Maksim KUDRIAVTSEV, Russian Federation, NR ; Mr Yury OLEINIKOV, Russian Federation, NR ; Ms Irina RODNINA, Russian Federation, NR ; Mr Roman ROMANENKO, Russian Federation, NR ; Ms Irina RUKAVISHNIKOVA, Russian Federation, NR ; Mr Shamsail SARALIEV, Russian Federation, NR

Origin

2021 - First part-session

In the draft resolution, at the end of paragraph 6, insert the following sentences:

"When taking such decisions we must take into account those categories of individuals who already possess antibodies to Covid-19 and are thus not needing primarily the vaccination, which leads to reducing the burden on vaccine industry and immunisation centres. In this context, where appropriate, we should aim first to examine a patient in order to detect before vaccination a possible presence of Covid-19 antibodies."